Browsing: FDA

In September, Health and Human Services Secretary Robert F. Kennedy Jr. fired the two vice chairs of the U.S. Preventive Services Task Force. This move was both unsurprising and troubling. The task force is a critical advisory body to HHS, reviewing scientific evidence to provide recommendations on whether private health insurers should be required to…

Health officials hoping to boost adoption of artificial intelligence in health care have been moving behind the scenes to address brewing conflict between states and the federal government over the technology.

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

The Department of Health and Human Services released a policy that will temporarily allow compounding pharmacies to manufacture some peptide products, increasing access to the experimental wellness therapies embraced by many in the Make America Healthy Again movement

The Food and Drug Administration published draft guidance on Tuesday that would streamline approvals of some individualized gene therapies, a win for rare disease advocates who have criticized the agency’s approach to these treatments

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Theapproval of daraxonrasib, a new life-extending drug for pancreatic cancer, is the biggest advance in decades against a notoriously hard-to-treat disease. But data readouts don’t show what those extra months mean to patients and their loved ones, or the immense re

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Until recently, a Manhattanite might venture no more than a few dozen blocks to find the world’s most sophisticated cancer treatment. Cutting-edge American medicines have helped reduce the U.S. cancer death rate by about a third since 1990, and New York City hospitals deliver some of the best care in the country.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.